ArticleMolecular neurodegeneration2025

RNA-Targeting CRISPR/CasRx system relieves disease symptoms in Huntington's disease models.

Yingqi Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.